Net Income
Net Income
Pfizer Net Income decreased by 24.1% to $2.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.4%, from $2.97B to $2.69B. Over 2 years (FY 2021 to FY 2024), Net Income shows a downward trend with a -39.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
Detailed definition
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
Peer comparison
The most common metric for evaluating company performance against industry competitors.
Metric ID:
net_incomeHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.56B | $8.15B | $3.39B | $7.86B | $9.91B | $8.61B | $4.99B | $5.54B | $2.33B | -$2.38B | $3.12B | $41.00M | $4.47B | $410.00M | $2.97B | $2.91B | $3.54B | $2.69B |
| QoQ Change | — | +46.4% | -58.3% | +131.8% | +26.0% | -13.1% | -42.0% | +11.0% | -58.0% | -202.4% | +230.8% | -98.7% | >999% | -90.8% | +623.7% | -1.9% | +21.7% | -24.1% |
| YoY Change | — | — | — | — | +78.1% | +5.7% | +47.2% | -29.5% | -76.5% | -127.7% | -43.8% | -98.2% | +287.4% | — | -4.8% | >999% | -20.7% | -9.4% |
Range-$2.38B – $9.91B
CAGR-15.7%
Avg YoY Growth+538.9%
Median YoY Growth-9.4%
Net Income at Other Companies
Frequently Asked Questions
- What is Pfizer's net income?
- Pfizer (PFE) reported net income of $2.69B in Q1 2026.
- How has Pfizer's net income changed year-over-year?
- Pfizer's net income decreased by 9.4% year-over-year, from $2.97B to $2.69B.
- What is the long-term trend for Pfizer's net income?
- Over 2 years (2021 to 2024), Pfizer's net income has grown at a -39.6% compound annual growth rate (CAGR), from $21.98B to $8.03B.
- What does net income mean?
- The total profit remaining after all costs, expenses, and taxes have been paid.